Replies to post #161042 on Cytodyn Inc (CYDY)

[CTMedic]

ombowstring,

That is a really good question.

In your opinion, how long can CytoDyn go on making "Incremental but inexorable progress"?/quote]

Certainly there are many here with far greater knowledge of finance and biotechs than I.

Cytodyn could sell as large block of shares, which many have suggested.
They could continue the (painful) monthly financing through Fife.
They could partner with/sell an indication to one of many BPs. (NASH, Covid [acute or LH/PACS], cancers, autoimmune)
They could engage OWS/BARDA or foreign entities for larger Covid trials.

Long story short, many opportunities with no objective evidence that Cytodyn will remain a going concern (despite the cautionary language in SEC filings).

I have been told by many, many reliable sources that both BPs and the FDA are very well aware of leronlimab. I am not naive and not an apologist for the missteps of Cytodyn management. Good intentions alone are often insufficient. I expect Cytodyn will partner at some point and lead forward.

Time will tell.

GLTU